Skip to content

Ketamine: all studies

Page 138 of 449: studies 1,371 to 1,380 of 4,486, newest first. Back to the ketamine overview

Research

Protocol for a randomised controlled trial of ketamine versus ketamine and behavioural activation therapy for adults with treatment-resistant depression in the community.

BMJ Open May 1, 2024 Ben Beaglehole, Richard Porter, Katie M. Douglas et al. 5 citations

Although short-term benefits follow parenteral ketamine for treatment-resistant major depressive disorder (TR-MDD), there are challenges that prevent routine use of ketamine by clinicians. These include acute dissociative effects of parenteral ketamine, high relapse rates following ketamine dosing and the uncertain role of psychotherapy. This randomised controlled trial (RCT) seeks to establish...

DOI: 10.1136/bmjopen-2024-084844 (opens in new tab) Full text (opens in new tab) Adult psychiatry Psychosocial intervention Depression treatment Ketamine therapy +2

Recurrent Serotonin Syndrome After Ketamine-assisted Electroconvulsive Therapy: A Case Report and Review of the Literature.

Journal of Psychiatric Practice May 1, 2024 Aniruddha Deka, Emmanuel Joseph, Neha Sharma et al. 3 citations

Serotonin (5-HT) syndrome (SS) consists of changes in mental status as well as autonomic and neuromuscular changes. Though not well understood, serotonergic pathways have been implicated in the mechanism of action of electroconvulsive therapy (ECT). Ketamine has been used as an induction agent in ECT and as therapy for treatment-resistant depression. Utilizing a case report and literature...

DOI: 10.1097/PRA.0000000000000787 (opens in new tab) Full text (opens in new tab) Depression treatment Drug interactions Serotonin syndrome Patient safety +1

A Case of Stress-Induced Cardiomyopathy After Ketamine Infusion.

Cureus May 1, 2024 Zach Hart, Thomas Anderson, Hanna Fanous et al. 2 citations

We report the case of a 64-year-old female with a history of hypothyroidism and isolated parotid sarcoidosis who presented with acute-onset chest pain and dyspnea. Echocardiogram demonstrated transiently reduced ejection fraction with apical hypokinesis, without evidence of obstructive coronary lesions on angiography, compatible with stress-induced cardiomyopathy. She received a ketamine...

DOI: 10.7759/cureus.59709 (opens in new tab) Full text (opens in new tab) Cardiac Imaging-MRI Catecholamine-induced myocardial toxicity Iv ketamine Stress induced cardiomyopathy +3

Effects of ketamine on the severity of depression and anxiety following postoperative mechanical ventilation: a single-blind randomized clinical trial in Iran.

Acute and critical care May 1, 2024 Seyedbabak Mojaveraghili, Fatemeh Talebi, Sima Ghorbanoghli et al. 1 citation

In this study, we compare the effects of ketamine and the combination of midazolam and morphine on the severity of depression and anxiety in mechanically ventilated patients after discharge from the intensive care unit (ICU). This randomized single-blind clinical trial included 50 patients who were candidates for craniotomy and postoperative mechanical ventilation in the ICU of 5 Azar Teaching...

Repurposing Ketamine in the Therapy of Depression and Depression-Related Disorders: Recent Advances and Future Potential.

Aging and disease April 29, 2024 Qianting Deng, Emily Parker, Chongyun Wu et al. 8 citations

Depression represents a prevalent and enduring mental disorder of significant concern within the clinical domain. Extensive research indicates that depression is very complex, with many interconnected pathways involved. Most research related to depression focuses on monoamines, neurotrophic factors, the hypothalamic-pituitary-adrenal axis, tryptophan metabolism, energy metabolism, mitochondrial...

DOI: 10.14336/AD.2024.0239 (opens in new tab) Full text (opens in new tab) Mental health Depression treatment Ketamine therapy Antidepressants

A retrospective analysis of iv ketamine outcome on hospitalisations in an unselected psychiatric sample.

Acta Neuropsychiatrica April 25, 2024 Karl Sandström, Olli Kampman, Peter Asellus 1 citation

This study aims to explore the outcome with iv ketamine treatment in a real-world clinical setting, primarily measured as posttreatment days hospitalised. The psychiatric medical records of 46 patients having received iv ketamine on a psychiatric treatment indication between 2015 and 2018 were retrospectively examined. Analysis comparing the number and duration of hospital admissions before and...

Ketamine and its enantiomers for depression: a bibliometric analysis from 2000 to 2023.

European Archives of Psychiatry and Clinical Neuroscience April 25, 2024 Li-Yuan Zhao, Guang-Fen Zhang, Xue-Jie Lou et al. 11 citations

Ketamine has demonstrated rapid and sustained antidepressant effects, marking its emergence as an innovative treatment of depression. Despite the growing number of preclinical and clinical studies exploring the antidepressant effects of ketamine and its enantiomers, a comprehensive bibliometric analysis in this field has yet to be conducted. This study employs bibliometric methods and...

A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of the Acute Antisuicidal and Antidepressant Effects of Intranasal (R,S)-Ketamine in Severe Unipolar and Bipolar Depression With and Without Comorbid Alcohol Use Disorder.

The Journal of Clinical Psychiatry April 24, 2024 Gregory H Jones, Courtney M Vecera, Ana C Ruiz et al. 13 citations

Objective: Although individuals with a family history of alcohol use disorder (AUD) have a superior antidepressant response to ketamine, outcomes in patients with current AUD remain unclear. This study sought to investigate whether intranasal (IN) racemic (R,S)-ketamine had antisuicidal and antidepressant effects in unipolar and bipolar depression and whether comorbid AUD conferred superior...

DOI: 10.4088/JCP.23m14974 (opens in new tab) Full text (opens in new tab) Depression Ketamine therapy Mental health treatment Substance abuse +1

Evaluation of Ketamine after subacute low dosage Lipopolysaccharide-activated Microglia produced depressive-like phenotype in mice

Research Journal of Pharmacy and Technology April 22, 2024 Shuvranshu Praharaj, Vandurayanpet Kaliyamoorthy Kalaichelvan, Vedigounder Murugan et al.

Depression is a common mental illness, with an estimated 3.8% of global population affected. Peripheral administration of lipopolysaccharide (LPS) culminate in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in the forced swim test (FST) and anhedonia in sucrose preference tests (SPT). After 6 days of LPS stimulation, we established a depression...

The Effect of Preprocedural Low-Dose Ketamine for Pain and Anxiety in Patients during Thoracic Epidural Catheterization.

Medicina (Kaunas, Lithuania) April 22, 2024 Onur Küçük, Esra Sarı, Musa Zengin et al. 2 citations

Background and Objectives: Thoracic epidural catheterization (TEC) can be both uncomfortable and fearful for patients when performed awake with the thought that the procedure may be painful. The aim of this study was to assess the effect of low-dose intravenous ketamine administration on pain and anxiety during the TEC procedure. Materials and Methods: Sixty patients were randomly divided into...

DOI: 10.3390/medicina60040679 (opens in new tab) Full text (opens in new tab) Ketamine Preprocedural low dose Thoracic epidural catheterization Pain management +4